Baseline Tumor Proliferation and Ki-67 Are Associated With Pathological Response to Neoadjuvant Chemoimmunotherapy in Non–Small Cell Lung Cancer
Modern Pathology · 2026-08 · 39 (8) · 101028
DOI: 10.1016/j.modpat.2026.101028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2026-08. Verfasst von Jianghua Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and I…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Ki-67 Antigen, Lung Neoplasms, Cell Proliferation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Heterogeneity in the pathological response to neoadjuvant chemoimmunotherapy underscores the need for predictive biomarkers in resectable non-small cell lung cancer (NSCLC). This study identified baseline molecular features-particularly tumor proliferation signatures-associated with pathological response. Two retrospective cohorts (test, n = 81; validation, n = 107) of patients with NSCLC who received neoadjuvant chemoimmunotherapy were analyzed. Bulk RNA sequencing was performed on baseline biopsies from the test cohort, with immunohistochemistry (IHC) for PD-L1 and Ki-67 in both cohorts. Outcomes included major pathological response (MPR), pathological complete response (pCR), and event-free survival. In the test cohort, transcriptomic analysis showed that responders had significant upregulation of proliferation-related genes (eg, TP63, SOX2, NTRK2, and HMGA2) and activation of proliferation signatures (eg, chromosomal instability signature and core embryonic stem cell-like module), without activation of canonical immune-inflamed pathways. PD-L1 expression had limited predictive value (area under the curves [AUCs], 0.56-0.59 for MPR and 0.52-0.54 for pCR). In contrast, proliferation markers demonstrated higher performance: MKI67 messenger RNA predicted both MPR and pCR with an AUC of 0.71, and the Ki-67 IHC index yielded AUCs of 0.71 for MPR and 0.64 for pCR. The predictive value of the Ki-67 IHC index was validated in the independent cohort, with AUCs of 0.74 for MPR and 0.70 for pCR, and this association was generally consistent across squamous cell carcinoma and adenocarcinoma. A Ki-67 index ≥50% was significantly correlated with improved event-free survival in both cohorts (both Ps < .05). These findings indicate baseline tumor proliferation, particularly MKI67/Ki-67, as predictors of pathological response in NSCLC patients receiving neoadjuvant chemoimmunotherapy, supporting its potential clinical utility for patient selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Institute, Beijing, China; Department of Pathology, School of Basic Med…
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Institute, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: lindm3@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Sun, W., Liu, X., Yang, X., Mao, L., Wang, C., Diao, X., Huang, X., & Lin, D. (2026). Baseline Tumor Proliferation and Ki-67 Are Associated With Pathological Response to Neoadjuvant Chemoimmunotherapy in Non–Small Cell Lung Cancer. Modern Pathology, 39(8), 101028. https://doi.org/10.1016/j.modpat.2026.101028
Vancouver
Wu J, Sun W, Liu X, Yang X, Mao L, Wang C, et al. Baseline Tumor Proliferation and Ki-67 Are Associated With Pathological Response to Neoadjuvant Chemoimmunotherapy in Non–Small Cell Lung Cancer. Modern Pathology. 2026;39(8):101028. doi:10.1016/j.modpat.2026.101028
BibTeX
@article{Wu2026,
author = {Wu, Jianghua and Sun, Wei and Liu, Xinying and Yang, Xin and Mao, Luning and Wang, Chenglong and Diao, Xinting and Huang, Xiaozheng and Lin, Dongmei},
title = {Baseline Tumor Proliferation and Ki-67 Are Associated With Pathological Response to Neoadjuvant Chemoimmunotherapy in Non–Small Cell Lung Cancer},
journal = {Modern Pathology},
year = {2026},
volume = {39},
number = {8},
pages = {101028},
doi = {10.1016/j.modpat.2026.101028}
}
EUVIMED